The global market for Infectious Disease Rapid Diagnostic Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Infectious Disease Rapid Diagnostic Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infectious Disease Rapid Diagnostic Testing by region & country, by Type, and by Application.

The Infectious Disease Rapid Diagnostic Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Rapid Diagnostic Testing.

Market Segmentation

Scope of Infectious Disease Rapid Diagnostic Testing - Market Report

Report Metric	Details
Report Name	Infectious Disease Rapid Diagnostic Testing - Market
CAGR	5%
Segment by Type:	Assays Platforms
Segment by Application	Respiratory Infection Gastro-Intestinal Infection Center Nervous System Infection Hospital Acquired Infection Sexually Transmitted Infections Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Roche Ltd, Danaher Corporation, Luminex Corporation, BGI Group, bioMerieux S.A., DiaSorin S.p.A, Hologic, Inc., Mesa Biotech, Quidel Corporation, Thermo Fisher Scientific Inc., GenMark Diagnostics, CTK Biotech, Becton Dickinson, Cellex Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Infectious Disease Rapid Diagnostic Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Infectious Disease Rapid Diagnostic Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Infectious Disease Rapid Diagnostic Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Infectious Disease Rapid Diagnostic Testing - Market report?

Ans: The main players in the Infectious Disease Rapid Diagnostic Testing - Market are Abbott Laboratories, Roche Ltd, Danaher Corporation, Luminex Corporation, BGI Group, bioMerieux S.A., DiaSorin S.p.A, Hologic, Inc., Mesa Biotech, Quidel Corporation, Thermo Fisher Scientific Inc., GenMark Diagnostics, CTK Biotech, Becton Dickinson, Cellex Inc.

What are the Application segmentation covered in the Infectious Disease Rapid Diagnostic Testing - Market report?

Ans: The Applications covered in the Infectious Disease Rapid Diagnostic Testing - Market report are Respiratory Infection, Gastro-Intestinal Infection, Center Nervous System Infection, Hospital Acquired Infection, Sexually Transmitted Infections, Others

What are the Type segmentation covered in the Infectious Disease Rapid Diagnostic Testing - Market report?

Ans: The Types covered in the Infectious Disease Rapid Diagnostic Testing - Market report are Assays, Platforms

1 Market Overview

1.1 Infectious Disease Rapid Diagnostic Testing Product Introduction

1.2 Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast

1.3 Infectious Disease Rapid Diagnostic Testing Market Trends & Drivers

1.3.1 Infectious Disease Rapid Diagnostic Testing Industry Trends

1.3.2 Infectious Disease Rapid Diagnostic Testing Market Drivers & Opportunity

1.3.3 Infectious Disease Rapid Diagnostic Testing Market Challenges

1.3.4 Infectious Disease Rapid Diagnostic Testing Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Infectious Disease Rapid Diagnostic Testing Players Revenue Ranking (2023)

2.2 Global Infectious Disease Rapid Diagnostic Testing Revenue by Company (2019-2024)

2.3 Key Companies Infectious Disease Rapid Diagnostic Testing Manufacturing Base Distribution and Headquarters

2.4 Key Companies Infectious Disease Rapid Diagnostic Testing Product Offered

2.5 Key Companies Time to Begin Mass Production of Infectious Disease Rapid Diagnostic Testing

2.6 Infectious Disease Rapid Diagnostic Testing Market Competitive Analysis

2.6.1 Infectious Disease Rapid Diagnostic Testing Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Infectious Disease Rapid Diagnostic Testing Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Rapid Diagnostic Testing as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Assays

3.1.2 Platforms

3.2 Global Infectious Disease Rapid Diagnostic Testing Sales Value by Type

3.2.1 Global Infectious Disease Rapid Diagnostic Testing Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Infectious Disease Rapid Diagnostic Testing Sales Value, by Type (2019-2030)

3.2.3 Global Infectious Disease Rapid Diagnostic Testing Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Respiratory Infection

4.1.2 Gastro-Intestinal Infection

4.1.3 Center Nervous System Infection

4.1.4 Hospital Acquired Infection

4.1.5 Sexually Transmitted Infections

4.1.6 Others

4.2 Global Infectious Disease Rapid Diagnostic Testing Sales Value by Application

4.2.1 Global Infectious Disease Rapid Diagnostic Testing Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Infectious Disease Rapid Diagnostic Testing Sales Value, by Application (2019-2030)

4.2.3 Global Infectious Disease Rapid Diagnostic Testing Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Infectious Disease Rapid Diagnostic Testing Sales Value by Region

5.1.1 Global Infectious Disease Rapid Diagnostic Testing Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Infectious Disease Rapid Diagnostic Testing Sales Value by Region (2019-2024)

5.1.3 Global Infectious Disease Rapid Diagnostic Testing Sales Value by Region (2025-2030)

5.1.4 Global Infectious Disease Rapid Diagnostic Testing Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Infectious Disease Rapid Diagnostic Testing Sales Value, 2019-2030

5.2.2 North America Infectious Disease Rapid Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Infectious Disease Rapid Diagnostic Testing Sales Value, 2019-2030

5.3.2 Europe Infectious Disease Rapid Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Infectious Disease Rapid Diagnostic Testing Sales Value, 2019-2030

5.4.2 Asia Pacific Infectious Disease Rapid Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Infectious Disease Rapid Diagnostic Testing Sales Value, 2019-2030

5.5.2 South America Infectious Disease Rapid Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Sales Value, 2019-2030

5.6.2 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Infectious Disease Rapid Diagnostic Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Infectious Disease Rapid Diagnostic Testing Sales Value

6.3 United States

6.3.1 United States Infectious Disease Rapid Diagnostic Testing Sales Value, 2019-2030

6.3.2 United States Infectious Disease Rapid Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Infectious Disease Rapid Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Infectious Disease Rapid Diagnostic Testing Sales Value, 2019-2030

6.4.2 Europe Infectious Disease Rapid Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Infectious Disease Rapid Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Infectious Disease Rapid Diagnostic Testing Sales Value, 2019-2030

6.5.2 China Infectious Disease Rapid Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.5.3 China Infectious Disease Rapid Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Infectious Disease Rapid Diagnostic Testing Sales Value, 2019-2030

6.6.2 Japan Infectious Disease Rapid Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Infectious Disease Rapid Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Infectious Disease Rapid Diagnostic Testing Sales Value, 2019-2030

6.7.2 South Korea Infectious Disease Rapid Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Infectious Disease Rapid Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Infectious Disease Rapid Diagnostic Testing Sales Value, 2019-2030

6.8.2 Southeast Asia Infectious Disease Rapid Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Infectious Disease Rapid Diagnostic Testing Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Infectious Disease Rapid Diagnostic Testing Sales Value, 2019-2030

6.9.2 India Infectious Disease Rapid Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

6.9.3 India Infectious Disease Rapid Diagnostic Testing Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Abbott Laboratories

7.1.1 Abbott Laboratories Profile

7.1.2 Abbott Laboratories Main Business

7.1.3 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.1.4 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.1.5 Abbott Laboratories Recent Developments

7.2 Roche Ltd

7.2.1 Roche Ltd Profile

7.2.2 Roche Ltd Main Business

7.2.3 Roche Ltd Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.2.4 Roche Ltd Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.2.5 Roche Ltd Recent Developments

7.3 Danaher Corporation

7.3.1 Danaher Corporation Profile

7.3.2 Danaher Corporation Main Business

7.3.3 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.3.4 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.3.5 Luminex Corporation Recent Developments

7.4 Luminex Corporation

7.4.1 Luminex Corporation Profile

7.4.2 Luminex Corporation Main Business

7.4.3 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.4.4 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.4.5 Luminex Corporation Recent Developments

7.5 BGI Group

7.5.1 BGI Group Profile

7.5.2 BGI Group Main Business

7.5.3 BGI Group Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.5.4 BGI Group Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.5.5 BGI Group Recent Developments

7.6 bioMerieux S.A.

7.6.1 bioMerieux S.A. Profile

7.6.2 bioMerieux S.A. Main Business

7.6.3 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.6.4 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.6.5 bioMerieux S.A. Recent Developments

7.7 DiaSorin S.p.A

7.7.1 DiaSorin S.p.A Profile

7.7.2 DiaSorin S.p.A Main Business

7.7.3 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.7.4 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.7.5 DiaSorin S.p.A Recent Developments

7.8 Hologic, Inc.

7.8.1 Hologic, Inc. Profile

7.8.2 Hologic, Inc. Main Business

7.8.3 Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.8.4 Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.8.5 Hologic, Inc. Recent Developments

7.9 Mesa Biotech

7.9.1 Mesa Biotech Profile

7.9.2 Mesa Biotech Main Business

7.9.3 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.9.4 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.9.5 Mesa Biotech Recent Developments

7.10 Quidel Corporation

7.10.1 Quidel Corporation Profile

7.10.2 Quidel Corporation Main Business

7.10.3 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.10.4 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.10.5 Quidel Corporation Recent Developments

7.11 Thermo Fisher Scientific Inc.

7.11.1 Thermo Fisher Scientific Inc. Profile

7.11.2 Thermo Fisher Scientific Inc. Main Business

7.11.3 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.11.4 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.11.5 Thermo Fisher Scientific Inc. Recent Developments

7.12 GenMark Diagnostics

7.12.1 GenMark Diagnostics Profile

7.12.2 GenMark Diagnostics Main Business

7.12.3 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.12.4 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.12.5 GenMark Diagnostics Recent Developments

7.13 CTK Biotech

7.13.1 CTK Biotech Profile

7.13.2 CTK Biotech Main Business

7.13.3 CTK Biotech Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.13.4 CTK Biotech Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.13.5 CTK Biotech Recent Developments

7.14 Becton Dickinson

7.14.1 Becton Dickinson Profile

7.14.2 Becton Dickinson Main Business

7.14.3 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.14.4 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.14.5 Becton Dickinson Recent Developments

7.15 Cellex Inc.

7.15.1 Cellex Inc. Profile

7.15.2 Cellex Inc. Main Business

7.15.3 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

7.15.4 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Revenue (US$ Million) & (2019-2024)

7.15.5 Cellex Inc. Recent Developments

8 Industry Chain Analysis

8.1 Infectious Disease Rapid Diagnostic Testing Industrial Chain

8.2 Infectious Disease Rapid Diagnostic Testing Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Infectious Disease Rapid Diagnostic Testing Sales Model

8.5.2 Sales Channel

8.5.3 Infectious Disease Rapid Diagnostic Testing Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific Inc

List of Tables

Table 1. Infectious Disease Rapid Diagnostic Testing Market Trends

Table 2. Infectious Disease Rapid Diagnostic Testing Market Drivers & Opportunity

Table 3. Infectious Disease Rapid Diagnostic Testing Market Challenges

Table 4. Infectious Disease Rapid Diagnostic Testing Market Restraints

Table 5. Global Infectious Disease Rapid Diagnostic Testing Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Infectious Disease Rapid Diagnostic Testing Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Infectious Disease Rapid Diagnostic Testing Product Type

Table 9. Key Companies Time to Begin Mass Production of Infectious Disease Rapid Diagnostic Testing

Table 10. Global Infectious Disease Rapid Diagnostic Testing Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Rapid Diagnostic Testing as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Infectious Disease Rapid Diagnostic Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Infectious Disease Rapid Diagnostic Testing Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Infectious Disease Rapid Diagnostic Testing Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Infectious Disease Rapid Diagnostic Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Infectious Disease Rapid Diagnostic Testing Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Infectious Disease Rapid Diagnostic Testing Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Infectious Disease Rapid Diagnostic Testing Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Infectious Disease Rapid Diagnostic Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Infectious Disease Rapid Diagnostic Testing Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Infectious Disease Rapid Diagnostic Testing Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Infectious Disease Rapid Diagnostic Testing Sales Value by Region (2019-2024) & (%)

Table 27. Global Infectious Disease Rapid Diagnostic Testing Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Infectious Disease Rapid Diagnostic Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Infectious Disease Rapid Diagnostic Testing Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Infectious Disease Rapid Diagnostic Testing Sales Value, (2025-2030) & (US$ Million)

Table 31. Abbott Laboratories Basic Information List

Table 32. Abbott Laboratories Description and Business Overview

Table 33. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 34. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of Abbott Laboratories (2019-2024)

Table 35. Abbott Laboratories Recent Developments

Table 36. Roche Ltd Basic Information List

Table 37. Roche Ltd Description and Business Overview

Table 38. Roche Ltd Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 39. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of Roche Ltd (2019-2024)

Table 40. Roche Ltd Recent Developments

Table 41. Danaher Corporation Basic Information List

Table 42. Danaher Corporation Description and Business Overview

Table 43. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 44. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of Danaher Corporation (2019-2024)

Table 45. Danaher Corporation Recent Developments

Table 46. Luminex Corporation Basic Information List

Table 47. Luminex Corporation Description and Business Overview

Table 48. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 49. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of Luminex Corporation (2019-2024)

Table 50. Luminex Corporation Recent Developments

Table 51. BGI Group Basic Information List

Table 52. BGI Group Description and Business Overview

Table 53. BGI Group Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 54. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of BGI Group (2019-2024)

Table 55. BGI Group Recent Developments

Table 56. bioMerieux S.A. Basic Information List

Table 57. bioMerieux S.A. Description and Business Overview

Table 58. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 59. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of bioMerieux S.A. (2019-2024)

Table 60. bioMerieux S.A. Recent Developments

Table 61. DiaSorin S.p.A Basic Information List

Table 62. DiaSorin S.p.A Description and Business Overview

Table 63. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 64. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of DiaSorin S.p.A (2019-2024)

Table 65. DiaSorin S.p.A Recent Developments

Table 66. Hologic, Inc. Basic Information List

Table 67. Hologic, Inc. Description and Business Overview

Table 68. Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 69. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of Hologic, Inc. (2019-2024)

Table 70. Hologic, Inc. Recent Developments

Table 71. Mesa Biotech Basic Information List

Table 72. Mesa Biotech Description and Business Overview

Table 73. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 74. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of Mesa Biotech (2019-2024)

Table 75. Mesa Biotech Recent Developments

Table 76. Quidel Corporation Basic Information List

Table 77. Quidel Corporation Description and Business Overview

Table 78. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 79. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of Quidel Corporation (2019-2024)

Table 80. Quidel Corporation Recent Developments

Table 81. Thermo Fisher Scientific Inc. Basic Information List

Table 82. Thermo Fisher Scientific Inc. Description and Business Overview

Table 83. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 84. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of Thermo Fisher Scientific Inc. (2019-2024)

Table 85. Thermo Fisher Scientific Inc. Recent Developments

Table 86. GenMark Diagnostics Basic Information List

Table 87. GenMark Diagnostics Description and Business Overview

Table 88. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 89. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of GenMark Diagnostics (2019-2024)

Table 90. GenMark Diagnostics Recent Developments

Table 91. CTK Biotech Basic Information List

Table 92. CTK Biotech Description and Business Overview

Table 93. CTK Biotech Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 94. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of CTK Biotech (2019-2024)

Table 95. CTK Biotech Recent Developments

Table 96. Becton Dickinson Basic Information List

Table 97. Becton Dickinson Description and Business Overview

Table 98. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 99. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of Becton Dickinson (2019-2024)

Table 100. Becton Dickinson Recent Developments

Table 101. Cellex Inc. Basic Information List

Table 102. Cellex Inc. Description and Business Overview

Table 103. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Products, Services and Solutions

Table 104. Revenue (US$ Million) in Infectious Disease Rapid Diagnostic Testing Business of Cellex Inc. (2019-2024)

Table 105. Cellex Inc. Recent Developments

Table 106. Key Raw Materials Lists

Table 107. Raw Materials Key Suppliers Lists

Table 108. Infectious Disease Rapid Diagnostic Testing Downstream Customers

Table 109. Infectious Disease Rapid Diagnostic Testing Distributors List

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

Table 113. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Infectious Disease Rapid Diagnostic Testing Product Picture

Figure 2. Global Infectious Disease Rapid Diagnostic Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Infectious Disease Rapid Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 4. Infectious Disease Rapid Diagnostic Testing Report Years Considered

Figure 5. Global Infectious Disease Rapid Diagnostic Testing Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Infectious Disease Rapid Diagnostic Testing Revenue in 2023

Figure 7. Infectious Disease Rapid Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Assays Picture

Figure 9. Platforms Picture

Figure 10. Global Infectious Disease Rapid Diagnostic Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Infectious Disease Rapid Diagnostic Testing Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Respiratory Infection

Figure 13. Product Picture of Gastro-Intestinal Infection

Figure 14. Product Picture of Center Nervous System Infection

Figure 15. Product Picture of Hospital Acquired Infection

Figure 16. Product Picture of Sexually Transmitted Infections

Figure 17. Product Picture of Others

Figure 18. Global Infectious Disease Rapid Diagnostic Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 19. Global Infectious Disease Rapid Diagnostic Testing Sales Value Market Share by Application, 2023 & 2030

Figure 20. North America Infectious Disease Rapid Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 21. North America Infectious Disease Rapid Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 22. Europe Infectious Disease Rapid Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 23. Europe Infectious Disease Rapid Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 24. Asia Pacific Infectious Disease Rapid Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 25. Asia Pacific Infectious Disease Rapid Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 26. South America Infectious Disease Rapid Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 27. South America Infectious Disease Rapid Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 28. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Sales Value (2019-2030) & (US$ Million)

Figure 29. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Sales Value by Country (%), 2023 VS 2030

Figure 30. Key Countries/Regions Infectious Disease Rapid Diagnostic Testing Sales Value (%), (2019-2030)

Figure 31. United States Infectious Disease Rapid Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 32. United States Infectious Disease Rapid Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 33. United States Infectious Disease Rapid Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 34. Europe Infectious Disease Rapid Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 35. Europe Infectious Disease Rapid Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 36. Europe Infectious Disease Rapid Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 37. China Infectious Disease Rapid Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 38. China Infectious Disease Rapid Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 39. China Infectious Disease Rapid Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 40. Japan Infectious Disease Rapid Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 41. Japan Infectious Disease Rapid Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 42. Japan Infectious Disease Rapid Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 43. South Korea Infectious Disease Rapid Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 44. South Korea Infectious Disease Rapid Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 45. South Korea Infectious Disease Rapid Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 46. Southeast Asia Infectious Disease Rapid Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 47. Southeast Asia Infectious Disease Rapid Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 48. Southeast Asia Infectious Disease Rapid Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 49. India Infectious Disease Rapid Diagnostic Testing Sales Value, (2019-2030) & (US$ Million)

Figure 50. India Infectious Disease Rapid Diagnostic Testing Sales Value by Type (%), 2023 VS 2030

Figure 51. India Infectious Disease Rapid Diagnostic Testing Sales Value by Application (%), 2023 VS 2030

Figure 52. Infectious Disease Rapid Diagnostic Testing Industrial Chain

Figure 53. Infectious Disease Rapid Diagnostic Testing Manufacturing Cost Structure

Figure 54. Channels of Distribution (Direct Sales, and Distribution)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Rapid Virus Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rapid Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Covid 19 Rapid Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Infectious Respiratory Disease Diagnostics Market Research Report 2025

Virus Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Infectious Diseases In Vitro Diagnostics Market Research Report 2024

Virus Testing Diagnostic Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease In vitro Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rapid Diagnostic Test RDTs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Point of Care Rapid Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti infectious Disease Drugs Market Research Report 2025

Global Hepatitis Viruses Diagnostic Tests Market Research Report 2024

Global Respiratory Infection Diagnostic Market Research Report 2024

Laboratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibiotic Resistance Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Toxoplasmosis Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions